Brain natriuretic peptide as an integrator of cardiovascular stiffening in hypertension
Introduction
Arterial hypertension is accompanied by augmented levels of vasoactive peptides such as brain natriuretic peptide (BNP), a reliable indicator of left ventricular (LV) pressure and/or volume overload [1], [2]. Although increased BNP levels are closely related with the impairment of LV systolic function [3], this is not always the case in the setting of hypertensive or ageing cardiovascular disease, where diastolic dysfunction may have a pivotal role [1], [4].
Increased arterial stiffness, cause and/or effect of hypertension, is an independent predictor of adverse cardiovascular events in various clinical settings. In a previous work, [5] carotid-femoral pulse wave velocity (c-f PWV), the most established measure of aortic stiffness in clinical practice, was associated with indices of LV diastolic function in the absence of LV hypertrophy. Although the pathophysiologic mechanisms underlying this relation are not yet completely elucidated, many speculations can be done, including the role of neurohumoral factors. In this concept, BNP has been associated with diverse indexes of LV diastolic performance, as well as with the severity of diastolic dysfunction [6], [7]. In the same lines, there are scarce data on the link between BNP and vascular wall properties [8].
In this study we investigated whether BNP levels are associated with aortic elastic properties in addition to LV diastolic dysfunction in newly diagnosed hypertensives without LV hypertrophy.
Section snippets
Study population
We studied 287 consecutive patients, (aged 52.3 years), with newly diagnosed (within the previous 2 years) untreated, stages I–II EH [office blood pressure (BP) = 148/95 mmHg], who referred to the outpatient hypertensive unit of our institution. The presence and severity of hypertension were determined on the basis of office BP measurements, according to ESH guidelines [9]. All subjects underwent the usual clinical and laboratory work-up in order to rule out secondary hypertension [9].
Patients
Statistical analysis
Data are expressed as mean ± SD or percentage, as appropriate. Differences in characteristics across tertiles were compared by ANOVA followed by Tukey's post hoc test for continuous variables and x2 analysis for dichotomous variables. Due to their skewed distribution, BNP levels were logarithmically transformed and descriptive statistics included medians and interquartile ranges. Univariate and multivariate analyses were performed in order to assess the determinants of logBNP using demographic,
Results
Based on the classification of the studied population into tertiles of BNP levels, hypertensives into the highest tertile (n = 67) were older than those classified into the lowest tertile (n = 67). Moreover, hypertensives in the highest tertile of BNP compared to those in the lowest tertile were characterized by lower office and 24 h diastolic BP levels (by 4.5 mmHg, p = 0.05 and 5.7 mmHg, p = 0.014, respectively), as well as by higher office and 24 h pulse pressure (by 6.1 mmHg, p = 0.025 and 6.2 mmHg, p
Discussion
The main finding of the present study is that BNP even within the normal range exhibit an association not only with indexes of LV diastolic function but also with c-f PWV independently of age in the early course of essential hypertension.
BNP levels are closely associated with LV hypertrophy and filling impairment [1], [3] and may be used to facilitate the diagnosis of LV diastolic dysfunction in hypertensives [6], [7]. In our study, despite the absence of LV hypertrophy and the absence of
Acknowledgement
The authors of this manuscript have certified that they comply with the Principles of Ethical Publishing in the International Journal of Cardiology [20].
References (20)
- et al.
Biochemical detection of left-ventricular systolic dysfunction
Lancet
(1998) - et al.
Prognostic role of B-type natriuretic peptide levels in patients with type 2 diabetes mellitus
J Am Coll Cardiol
(2004) - et al.
Plasma B-type natriuretic peptide reflects left ventricular hypertrophy and diastolic function in hypertension
Int J Cardiol
(2004) - et al.
Utility of B-natriuretic peptide in the evaluation of left ventricular diastolic function: comparison with tissue Doppler imaging recordings
Am Heart J
(2004) - et al.
B-type natriuretic peptide and arterial stiffness in healthy Japanese men
Am J Hypertens
(2006) - et al.
Radial augmentation index associated with increase in B-type natriuretic peptide in patients with hypertension
Int J Cardiol
(2008) Ethical authorship and publishing
Int J Cardiol
(2009)- et al.
Bedside tests of B-type natriuretic peptide in the diagnosis of left ventricular diastolic dysfunction in hypertensive patients
Eur J Heart Fail
(2005) - et al.
Plasma brain natriuretic levels and blood pressure tracking in the Framingham Heart Study
Hypertension
(2003) - et al.
Left ventricular diastolic dysfunction is accompanied by increased aortic stiffness in the early stages of essential hypertension: a TDI approach
J Hypertens
(2005)
Cited by (18)
Takayasu's Arteritis
2017, The Heart in Rheumatic, Autoimmune and Inflammatory Diseases: Pathophysiology, Clinical Aspects and Therapeutic ApproachesAssociation of left ventricular longitudinal and circumferential systolic dysfunction with diastolic function in hypertension: A nonlinear analysis focused on the interplay with left ventricular geometry
2014, Journal of Cardiac FailureCitation Excerpt :Natriuretic peptide plasma concentrations were not assessed. Because natriuretic peptide levels are increased in hypertensive patients with diastolic dysfunction,46 an analysis aimed at exploring the interaction among different components of LV systolic shortening, LV diastolic indexes, and natriuretic peptide levels in patients with hypertension may be of clinical interest. By design, our study population included asymptomatic subjects in New York Heart Association functional class I.
N-terminal pro-b-type natriuretic peptide and longitudinal risk of hypertension
2021, American Journal of HypertensionSubclinical target organ damage in normotensive and prehypertensive patients
2017, Minerva CardioangiologicaN-terminal pro-B-type natriuretic peptide is associated with arterial stiffness as measured according to the brachial-ankle pulse wa ve velocity in patients with Takayasu arteritis
2015, Journal of Atherosclerosis and Thrombosis